Activotec Ltd launched Activo-Darwin Semi-Automated Peptide Synthesizer a instrument designed for the synthesis of very high quality peptides.
The global peptide synthesis market continues to accelerate as the demand for peptide-based therapeutics intensifies across oncology, metabolic disorders, autoimmune diseases, and rare conditions. Valued at US$0.81 billion in 2024, the market is projected to reach US$1.41 billion by 2029, advancing at a strong CAGR of 11.7%. This remarkable growth is fueled by advancements in solid-phase peptide synthesis (SPPS), expanding applications in precision medicine, and increasing investments in biopharmaceutical R&D.
Peptides have emerged as a preferred therapeutic modality due to their high specificity, favorable safety profile, and broad applicability in targeted drug delivery, vaccines, biomarker discovery, and diagnostics. As the pharmaceutical and biotechnology sectors push toward innovative, customized therapies, the demand for efficient peptide synthesis platforms — both products and services — continues to rise.
Download PDF Brochure
Market Drivers: What’s Powering the Demand for Peptide Synthesis?
Several major forces are shaping the strong trajectory of the peptide synthesis market:
* Growing Use of Peptide-based Therapeutics
Peptides are increasingly used in the treatment of cancer, diabetes, obesity, and cardiovascular diseases, prompting pharmaceutical companies to invest heavily in peptide drug development pipelines.
* Advancements in SPPS and Hybrid Approaches
Technological innovations such as automated peptide synthesizers, improved resins, and optimized coupling reagents have made peptide production faster, more economical, and highly scalable. Hybrid synthesis approaches further streamline complex peptide design and customization.
* Expansion of Precision Medicine and Custom Peptide Synthesis
The rise of personalized medicine has significantly increased the need for custom peptide synthesis for tailored therapies, neoantigen vaccines, and biomarker research.
* Integration of Automation and AI
Automation, robotics, and AI-driven workflow optimization are transforming peptide synthesis instruments, improving yield accuracy, reducing manual errors, and enabling high-throughput synthesis.
Market Segmentation Insights
* Products Lead the Peptide Synthesis Offerings Segment
The market is broadly segmented into products and services, with products holding the largest share in 2023.
Consumables Dominate the Product Category
Consumables — including resins, amino acids, coupling reagents, dyes, labeling reagents, cleavage agents, and other synthesis reagents — are essential for every peptide synthesis workflow. Their recurring nature ensures consistent demand.
Growing research activities in proteomics, drug delivery, and peptide engineering further contribute to the rapid adoption of high-purity reagents.
Instruments Segment Gains Momentum
The instruments market includes:
* Peptide synthesizers (automated & manual)
* Chromatography equipment
* Lyophilizers
* Other auxiliary instruments
Automation is becoming a core requirement across biotech R&D environments. Companies are launching new synthesizers to enhance throughput and purity. For example, in May 2024, Activotec Ltd. introduced the Activo-Darwin Semi-Automated Peptide Synthesizer, engineered for high-quality peptide production with improved reagent management.
* Peptide Synthesis Services Expected to Grow Rapidly
The services segment includes:
* Custom peptide synthesis
* Peptide library synthesis
* Peptide purification
* Peptide analytical services
Leading providers such as Bachem, GenScript, and Thermo Fisher Scientific dominate this space, offering advanced services for long-chain peptides, complex modifications, and GMP-grade manufacturing.
The rising complexity of therapeutic peptides — featuring non-natural amino acids, long sequences, and multifunctional structures — has increased outsourcing demand, driving strong CAGR growth in the services segment.
* Solid-Phase Peptide Synthesis (SPPS) Remains the Gold Standard
Among synthesis techniques — chemical and biological — chemical synthesis, particularly solid-phase peptide synthesis (SPPS), leads the market.
Why SPPS Leads the Market
* High efficiency and short production times
* Compatibility with automation and large-scale operations
* Simplified purification processes
* Greater flexibility for complex peptide sequences
Biological methods such as recombinant DNA technology and enzymatic synthesis are expanding but remain complementary to chemical synthesis workflows.
* Therapeutic Applications — Cancer Leads the Market
The peptide synthesis market is segmented into therapeutics, diagnostics, and research applications. Within therapeutics, oncology holds the largest share due to the rise of:
* Peptide-based cancer vaccines
* Peptide-drug conjugates (PDCs)
* Targeted peptide inhibitors
* Immunotherapy-driven peptide design
The growing need for biomarkers, targeted delivery, and tumor-specific peptides positions the oncology segment as a pivotal growth driver.
* Pharmaceutical & Biotechnology Companies Remain the Largest End Users
Pharma and biotech companies dominate due to:
* Rising investment in peptide-based therapeutics
* Increased adoption of automated synthesizers
* Growing demand for GMP-compliant peptide manufacturing
* Expansion of clinical trial pipelines
CDMOs and CROs also play a significant role, especially as companies outsource complex or large-scale peptide synthesis tasks.
Regional Insights: North America Leads, APAC Accelerates
North America Dominates the Global Market
North America holds the largest market share driven by:
* Strong presence of leading peptide manufacturers
* High R&D investments
* Robust adoption of advanced synthesis technologies
* Growing pipeline of peptide therapeutics
In the U.S., innovation continues to accelerate. For example, Cambrex introduced a new liquid-phase peptide synthesis (LPPS) technology in September 2024 that reduces reagent excess and solvent consumption — improving sustainability and process efficiency.
Request Sample Report
Asia Pacific Exhibits the Fastest Growth
The APAC region is witnessing strong growth due to:
* Expanding biotech infrastructure
* Increasing pharmaceutical manufacturing
* Rising demand for peptide-based therapies
* Growing R&D investments in China, India, South Korea, and Japan
APAC is quickly emerging as a global hub for peptide production, outsourcing, and biologics manufacturing.
Competitive Landscape
Leading players in the peptide synthesis market include:
* Thermo Fisher Scientific (US)
* Merck KGaA (Germany)
* Kaneka Corporation (Japan)
* GenScript Biotech (China)
* Bachem Holding AG (Switzerland)
These companies are expanding portfolios across reagents, synthesizers, purification systems, and custom peptide manufacturing services.
Conclusion
The global peptide synthesis market is entering an accelerated growth phase driven by rising therapeutic adoption, advanced synthesis technologies, expanding clinical pipelines, and strong investments in precision medicine. With increasing demand for high-purity peptides, automated systems, and complex custom synthesis, both established players and emerging innovators will play critical roles in shaping the future of peptide therapeutics and diagnostics.
News From
MarketsandMarkets™
Category: Industry Reports & Market Analysis Profile: About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, w …
This email address is being protected from spambots. You need JavaScript enabled to view it.
